Patents

8. Fang D, Tang A, Zhang X, Gao B. Methods of treating diseases and disorders associated with foxp3 expression. [US provisional patent application number 63/782,552]

7. Zhang X, Basu A. Compounds and methods for fbxw7-r465c-mediated protein degradation. [US provisional patent application number 63/722,709]

6. Zhang X, Zhang C, Zhou C. “Compositions and methods for screening and identifying immune modulators.” [US provisional patent application number 63/568,719]

5. Zhang X, Basu A. “Compounds and methods for fbxo22-mediated protein degradation.” [US provisional patent application number 63/538,637]

4. Cravatt B, Tao Y, Zhang X, Remillard D, Vinogradova E, Yokoyama M, Melillo B, Schreiber S. “Bifunctional degraders comprising electrophilic PROTACs that engage DCAF1 and pharmaceutical compositions comparing the same” WO2023225625.

3. Cravatt B, Vinogradova E, Crowley V, Zhang X, Schafroth, MA, Yokoyama M, Remillard D, Melillo B, Schreiber S. “An Activity-Guided Map of Electrophile-Cysteine Interactions in Primary Human Immune Cells” WO2021076755, CA3161949, EP4045050.

2. Zhang X, Crowley V, Cravatt B. “Compounds and methods for DCAF-mediated protein degradation” WO2020077278, US20200190105, EP3864030.

1. Ma Z, Zhao X, Zhang X. “Application of thiophenes for anti-cancer activity” CN101601668A.